FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Beth Pulaski

Research Profile

Living Beings

Physiology

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Erika A Danna; Pratima Sinha; Mileka Gilbert; Virginia K Clements; Beth A Pulaski; Suzanne Ostrand-Rosenberg
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.
Beth A Pulaski; Mark J Smyth; Suzanne Ostrand-Rosenberg
Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Beth A Pulaski; Suzanne Ostrand-Rosenberg
Mouse 4T1 breast tumor model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Beth Pulaski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Erika A Danna; Pratima Sinha; Mileka Gilbert; Virginia K Clements; Beth A Pulaski; Suzanne Ostrand-Rosenberg
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.
Cancer research 2004;64(6):2205-11.
2002: Beth A Pulaski; Mark J Smyth; Suzanne Ostrand-Rosenberg
Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Cancer research 2002;62(15):4406-12.
2001: Beth A Pulaski; Suzanne Ostrand-Rosenberg
Mouse 4T1 breast tumor model.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 20():Unit 20.2.
2000: Beth A Pulaski; D S Terman; S Khan; E Muller; Suzanne Ostrand-Rosenberg
Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.
Cancer research 2000;60(10):2710-5.
2000: Beth A Pulaski; Virginia K Clements; M R Pipeling; Suzanne Ostrand-Rosenberg
Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
Cancer immunology, immunotherapy : CII 2000;49(1):34-45.
1999: Suzanne Ostrand-Rosenberg; Beth A Pulaski; Virginia K Clements; Ling Qi; M R Pipeling; Laura Hanyok
Cell-based vaccines for the stimulation of immunity to metastatic cancers.
Immunological reviews 1999;170():101-14.
1998: KY Yeh; A J McAdam; Beth A Pulaski; N Shastri; john frelinger; Edith M Lord
IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):5773-80.
1998: TD Armstrong; Beth A Pulaski; Suzanne Ostrand-Rosenberg
Tumor antigen presentation: changing the rules.
Cancer immunology, immunotherapy : CII 1998;46(2):70-4.
1998: Beth A Pulaski; Suzanne Ostrand-Rosenberg
Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
Cancer research 1998;58(7):1486-93.
1998: Suzanne Ostrand-Rosenberg; Beth A Pulaski; TD Armstrong; Virginia K Clements
Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines.
Advances in experimental medicine and biology 1998;451():259-64.
1996: Beth A Pulaski; K Y Yeh; N Shastri; K M Maltby; DP Penney; E M Lord; john frelinger
Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(8):3669-74.
1995: K Y Yeh; Beth A Pulaski; M L Woods; A J McAdam; Anthony Gaspari; john frelinger; E M Lord
B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.
Cellular immunology 1995;165(2):217-24.
1995: A J McAdam; Beth A Pulaski; E Storozynsky; K Y Yeh; J Z Sickel; john frelinger; E M Lord
Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor.
Cellular immunology 1995;165(2):183-92.
1995: A J McAdam; Beth A Pulaski; S S Harkins; E K Hutter; E M Lord; john frelinger
Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells.
International journal of cancer. Journal international du cancer 1995;61(5):628-34.
1994: A J McAdam; A Felcher; M L Woods; Beth A Pulaski; E K Hutter; john frelinger; E M Lord
Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(3):155-64.
1993: A J McAdam; K Y Yeh; Beth A Pulaski; john frelinger; E M Lord
Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(4):293-7.
1993: A McAdam; Beth A Pulaski; S Harkins; E Hutter; john frelinger; E Lord
Coexpression of IL-2 and gamma-IFN enhances tumor immunity.
Annals of the New York Academy of Sciences 1993;690():349-51.
1993: E Lord; A McAdam; A Felcher; M Woods; Beth A Pulaski; E Hutter; john frelinger
Transfection of TGF-beta producing tumors with IL-2 elicits tumor rejection.
Annals of the New York Academy of Sciences 1993;690():346-8.
1993: Beth A Pulaski; A J McAdam; E K Hutter; S Biggar; E M Lord; john frelinger
Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.
Cancer research 1993;53(9):2112-7.
1991: M Moritz; Beth A Pulaski; John L Woolford
Assembly of 60S ribosomal subunits is perturbed in temperature-sensitive yeast mutants defective in ribosomal protein L16.
Molecular and cellular biology 1991;11(11):5681-92.
1971: D Stone; E Matalka; Beth A Pulaski
Do artificial sweeteners ingested in pregnancy affect the offspring?
Nature 1971;231(5297):53.